MCRB
Seres Therapeutics Inc
2.90$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 201.8% | -235.3% | -222.4% | -221.8% | -281.8% | 4.6% | -3,210.1% | -92.9% | – | 141.6% | |
| – | – | – | – | 19.3% | 22.6% | 27.8% | 22.0% | 19.8% | 4.1% | 93.0% | 4.9% | – | 523.8% | |
| – | – | – | – | 77.4% | 54.1% | 58.9% | 24.2% | 26.6% | 14.0% | 357.5% | 27.0% | – | 1,373.9% | |
| – | – | – | – | 77.4% | 54.1% | 58.9% | 25.3% | 26.6% | 16.8% | 357.5% | – | – | – | |
| – | – | – | – | 527.5% | -32.9% | 41.7% | -71.4% | -69.8% | 28.7% | -258.0% | -46.7% | – | -3,520.9% | |
| – | – | – | – | 98.7% | 14.6% | 6.9% | 2.9% | 1.8% | 6.6% | 137.8% | 6.3% | – | 31.9% | |
| – | – | – | – | -300.7% | 177.5% | 397.3% | -88.4% | -478.4% | 44.2% | 1,156.4% | 8.4% | – | -5.3% | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | 9.8% | -0.1% | -0.7% | 176.7% | 778.7% | 1.5% | 1,395.3% | – | – | – | |
| – | – | – | – | 114.9% | 77.9% | 88.4% | 71.2% | -2.9% | -0.7% | 360.5% | 40.0% | – | 0.0% | |
| – | – | – | – | 9.8% | 0.3% | 0.9% | 249.9% | 913.5% | 0.8% | 1,818.2% | 56.8% | – | 1,761.5% | |
| – | – | – | – | -89.1% | -57.5% | 175.9% | -60.3% | 153.3% | 49.6% | -235.5% | -27.8% | – | 1,897.7% | |
| – | – | – | – | 103.0% | -249.8% | -229.2% | -224.7% | -283.6% | -2.0% | -3,347.9% | -99.2% | – | 109.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.